Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

ACP Journal Club. Review: Nicotine replacement therapy increases CVD events; bupropion and varenicline do not.

Rowland K.

Ann Intern Med. 2014 Apr 15;160(8):JC2. doi: 10.7326/0003-4819-160-8-201404150-02002. No abstract available.

PMID:
24733219
2.

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ.

Circulation. 2014 Jan 7;129(1):28-41. doi: 10.1161/CIRCULATIONAHA.113.003961. Epub 2013 Dec 9.

3.

Network meta-analysis demonstrates the safety of pharmacotherapy for smoking cessation in cardiovascular patients.

Pipe AL.

Evid Based Med. 2014 Oct;19(5):193. doi: 10.1136/eb-2014-110030. Epub 2014 Jun 4. No abstract available.

PMID:
24917603
4.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
5.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
6.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
7.

Smoking cessation: benefits versus risks of using pharmacotherapy to quit.

Samet JM.

Circulation. 2014 Jan 7;129(1):8-10. doi: 10.1161/CIRCULATIONAHA.113.006928. Epub 2013 Dec 9. No abstract available.

8.

Practical implementation of varenicline as an aid to smoking cessation in clinical practice.

Tonstad S.

Pneumologia. 2009 Jul-Sep;58(3):167-74. Review.

PMID:
19817313
9.

Suicidal behavior and depression in smoking cessation treatments.

Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S.

PLoS One. 2011;6(11):e27016. doi: 10.1371/journal.pone.0027016. Epub 2011 Nov 2.

10.
11.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
12.

Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.

Taylor M, Leonardi-Bee J, Agboola S, McNeill A, Coleman T.

Addiction. 2011 Oct;106(10):1819-26. doi: 10.1111/j.1360-0443.2011.03493.x. Epub 2011 Jul 27.

PMID:
21561499
13.
14.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
15.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
16.

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.

PMID:
22406881
17.

The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.

Kistler CE, Goldstein AO.

Nicotine Tob Res. 2012 Dec;14(12):1391-3. doi: 10.1093/ntr/nts028. Epub 2012 Mar 15. No abstract available.

PMID:
22422928
18.

Varenicline and bupropion: suicide.

[No authors listed]

Prescrire Int. 2012 Oct;21(131):240. No abstract available.

PMID:
23189376
19.

Smoking cessation.

Rennard SI, Daughton DM.

Clin Chest Med. 2014 Mar;35(1):165-76. doi: 10.1016/j.ccm.2013.11.002. Review.

PMID:
24507844
20.

Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):24-34. doi: 10.3810/hp.2012.02.945.

PMID:
22406880

Supplemental Content

Support Center